Good news for those who develop vaccine-induced prothrombotic immune thrombocytopenia after getting the COVID-19 vaccine! You might survive if you get treated soon after symptoms appear.
If you’ve never heard of VIPIT, you’re not alone. It’s a brand new health condition caused by the new vaccines.
VIPIT is one of many different adverse events reported so far. The May 7, 2021 VAERS report contained 192,954 total adverse events, including:
- 4057 deaths
- 17,190 serious injuries
- 297 miscarriages or premature births
- 1950 cases of Bell’s Palsy
- 181 cases of Guillain-Barré Syndrome
- 55,220 cases of anaphylaxis
What is Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT)?
Vaccine-Induced Prothrombotic Immune Thrombocytopenia seems to be uniquely connected to the Johnson & Johnson and AstraZeneca vaccines.
(VIPIT) is characterized by the presence of two conditions concurrently: thrombosis (often in unusual sites like the cerebral sinus veins or splanchnic veins) AND thrombocytopenia.American College of Cardiology
To make things a little more confusing, VIPIT is also called Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) and “thrombotic thrombocytopenic syndrome” (TTS).
(In those who develop VIPIT, the vaccine) seems to induce the production of antibodies causing massive activation of platelets via the Fc receptor, resembling heparin-induced thrombocytopenia (HIT), but without previous contact with heparin (HIT mimicry).”Thaler, J, et al.
In the case of VIPIT, some of the following symptoms appear four to 28 days after vaccination. This is important because people typically think of adverse events as taking place within 48 hours. That’s not the case here.
|Symptoms of Thrombosis|
|Back pain||Blood blisters|
|Blurred vision||Chest or abdominal pain|
|Double vision||Focal neurological symptoms|
|Multiple small bruises||Pallor and coldness in a limb|
|Persistent and severe headache||Reddish or purplish spots|
|Seizures||Shortness of breath|
|Swelling and redness in a limb||Unusual bleeding|
Most VIPIT cases have occurred in otherwise healthy people under 50 who did not have pre-existing health conditions. Rates are higher in women than men as well. If not treated quickly, mortality rates are as high as 50%.
Thanks to one patient’s medical team, the Journal of Thrombosis and Haemostasis was able to publish a detailed case report of this 62-year-old woman. The complete case report is available here. I’ve summarized it below.
Published Case Study
She developed flu-like symptoms the day after vaccination, treated herself, and felt better the day after that. She then took a short trip and cross-country skied for several hours in Austria.
On the 5th day, she developed chills, self-medicated, and felt better the next day.
On the 8th day, she bit her lip and developed a large hematoma. The next day, she noticed another hematoma on her ankle and that her gums were bleeding.
After much testing, the doctors diagnosed her VIPIT. Her treatment included:
- a fibrinogen concentrate
- HIT-compatible anticoagulation with short-acting danaparoid-sodium
- oral apixaban
That’s a lot of medication to offset the effects of a vaccine you could argue she didn’t need.
Read also: How are COVID-19 cases counted?
Think for yourself. Don’t let a celebrity do it for you.
Based on all of the celebrity endorsements, the pleading and incentivizing by Democrat governors, and the shaming by Mainstream Media of those who choose not to get vaccinated, you might believe the vaccine is safe and well-proven. But, unfortunately, that could not be further from the truth.
While it is true that the vast majority of people who’ve gotten one of the vaccines are alive and well today, they’re not without risk. In addition, there is no long-term safety data to show they’ll be fine long-term. Finally, don’t forget that none of these vaccines were available a year ago, and previous mRNA vaccines trialed on animals led to numerous problems.
The fact of the matter is, those who’ve been vaccinated are willing participants in a long-term safety study. Unfortunately, we won’t know the results of that study for years to come. Meanwhile, there is a risk in short-term adverse events as well, which cost the lives of more than 4000 people so far, many of whom were young and healthy when they died.
In the end, if you decide to get the vaccine or already did, that’s your choice. But it’s no more virtuous than those who choose not to get it.
Unmasked. Unmuzzled. Unvaccinated. Unafraid.
Make a statement without saying a word.
“CDC Data Show 4,000+ Reported Deaths Following COVID Vaccines as Kids 12 and Older Now Eligible • Children’s Health Defense.” Children’s Health Defense, https://childrenshealthdefense.org/defender/vaers-cdc-data-reported-deaths-covid-vaccines-kids-12-now-eligible/. Accessed 20 May 2021.
Cines, Douglas B., and James B. Bussel. “SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia.” New England Journal of Medicine, vol. 0, no. 0, Massachusetts Medical Society, Apr. 2021, p. null. Taylor and Francis+NEJM, doi:10.1056/NEJMe2106315.
Thaler, Johannes, et al. “Successful Treatment of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT).” Journal of Thrombosis and Haemostasis: JTH, Apr. 2021. PubMed, doi:10.1111/jth.15346.
“Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID-19 Vaccination.” Ontario COVID-19 Science Advisory Table, doi:10.47326/ocsat.2021.02.17.2.0. Accessed 20 May 2021.
“Vaccine-Induced Prothrombotic Immune Thrombocytopenia: Key Concerns.” European Pharmaceutical Review. www.europeanpharmaceuticalreview.com, https://www.europeanpharmaceuticalreview.com/article/152978/vaccine-induced-prothrombotic-immune-thrombocytopenia-pathogenetic-and-epidemiological-issues-of-concern/. Accessed 20 May 2021.
“Vaccine-Induced Thrombotic Thrombocytopenia (VITT) and COVID-19 Vaccines: What Cardiovascular Clinicians Need to Know.” American College of Cardiology, http%3a%2f%2fwww.acc.org%2flatest-in-cardiology%2farticles%2f2021%2f04%2f01%2f01%2f42%2fvaccine-induced-thrombotic-thrombocytopenia-vitt-and-covid-19-vaccines. Accessed 20 May 2021.